Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,801–1,900 of 2,883
Photoactivatable Exosenolytics Activate Natural Killer Cells for Delaying Osteoarthritis
Zhang, L., Xiang, K., Li, J., Hao, M., Zhu, Z., Wang, S., & Sun, H. (2025) · ACS Nano · doi:10.1021/acsnano.5c03344 · Cited by 15
Characterizing primary and secondary senescence in vivo
Sogabe, Y., Shibata, H., Kabata, M., Tanaka, A., Mitsunaga, K., Sunadome, K., Nakajima‐Koyama, M., Hirano, M., Nishida, E., Woltjen, K., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00917-y · Cited by 16
“Although the landmark study by Baker et al. 18 , using an elegant transgenic mouse model to eliminate senescent cells expressing p16 Ink4a from aged mice, showed amelioration of aging-associated disorders and even promotes longevity, as p16 Ink4a is not expressed in all senescent cells and not…”
Hepatic gene body hypermethylation is a shared epigenetic signature of murine longevity
Hahn, O., Stubbs, T. M., Reik, W., Grönke, S., Beyer, A., & Partridge, L. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007766 · Cited by 11
Targeted Therapeutics Delivery by Exploiting Biophysical Properties of Senescent Cells
Low, J., Chan, B., & Tay, A. K. P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107990 · Cited by 11
A Cellular Senescence-Centric Integrated Approach to Understanding Organismal Aging
Sharma, R., & Diwan, B. (2022) · Current Aging Science · doi:10.2174/1874609815666220914104548 · Cited by 9
Du, X., zhang, X., Qi, Z., Zeng, Z., Xu, Y., Yu, Z., Cao, X., & Xia, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.09.020 · Cited by 10
“One illuminating case study was that the depletion of senescent cells in aging mice reduced the incidences of spontaneous tumorigenesis and cancer-associated death [41].”
BackgroundImpact of Senescent Cell‐Derived Extracellular Vesicles on Innate Immune Cell Function
Chen, Y., Sullivan, J., Hanley, S., Price, J. M. J., Tariq, M. A., McIlvenna, L. C., Whitham, M., Sharma‐Oates, A., Harrison, P., Lord, J. M., et al. (2024) · Advanced Biology · doi:10.1002/adbi.202400265 · Cited by 11
Braga, C. E. H. V. P. F., de Brito, J. S., Ribeiro, M. M., Coutinho‐Wolino, K. S., Regis, B., Calixto, B., Rodrigues, R. C. B., Wang, A. Y.-M., Stenvinkel, P., & Mafra, D. (2025) · Biochimie · doi:10.1016/j.biochi.2025.10.008 · Cited by 19
Wakita, M., Ito, K., Fujii, K., Sakamoto, D., Mikawa, T., Sugawara, S., Zhou, X., Park, J. H., Miyagawa, H., Motooka, D., et al. (2026) · Nature Aging · doi:10.1038/s43587-025-01057-z · Cited by 9
Principles of alternative gerontology
Biliński, T., Bylak, A., & Zadrąg‐Tęcza, R. (2016) · Aging · doi:10.18632/aging.100931 · Cited by 10
Rewinding the Clock: Emerging Pharmacological Strategies for Human Anti-Aging Therapy
Delrue, C., Speeckaert, R., & Speeckaert, M. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199372 · Cited by 14
Shao, C., Zhang, Y., Li, H., Chen, J., Huang, T., Li, J., Wen, S., Wang, S., Fan, S., & Zhao, Y. (2024) · 癌症:英文版 · doi:10.1002/cac2.12636 · Cited by 12
“For normal tissue cells, whether cellular senescence is defined as an irreversible and ultimate fate [63] or a transcription factor-driven invertible cell state [64] is debated.”
A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Niazi, S. K. (2023) · Pharmaceuticals · doi:10.3390/ph16111556 · Cited by 13
Aging-dependent YAP1 reduction contributes to AD pathology by upregulating the Nr4a1-AKT/GSK-3β axis
Lei, L., Cheng, Y., Yin, A., Han, J.-M., Wu, G., Yang, F., Wang, Q., Wang, J., Liu, R., Li, H., et al. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00487-4 · Cited by 17
Sumida, K., Han, Z., Dashputre, A. A., Potukuchi, P. K., & Kovesdy, C. P. (2020) · Aging · doi:10.18632/aging.103685 · Cited by 8
An evaluation of the role of miR-361-5p in senescence and systemic ageing
Manni, E., Jeffery, N. M., Chambers, D., Slade, L., Etheridge, T., & Harries, L. W. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112127 · Cited by 10
Suzuki, Y., Takaya, K., Watanabe, S., Otaki, M., Kono, H., & Kishi, K. (2022) · Aging · doi:10.18632/aging.203966 · Cited by 9
Tau protein aggregation induces cellular senescence in the brain
(2018) · doi:10.1101/369074 · Cited by 595
The roles of radio-functional natural chemicals for the development of cancer radiation therapy
Jiang, L., & Iwahashi, H. (2018) · Reviews on Environmental Health · doi:10.1515/reveh-2018-0057 · Cited by 9
Yoshida, Y., Shimizu, I., Hayashi, Y., Ikegami, R., Suda, M., Katsuumi, G., Wakasugi, T., Nakao, M., Nakagami, H., Morishita, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40325-y · Cited by 10
Accelerated Aging in Cyclophilin B–Deficient Mice Downstream of p21‐Cip1 /Waf1
Zhang, Y., Pignolo, R. J., & Bram, R. J. (2022) · JBMR Plus · doi:10.1002/jbm4.10674 · Cited by 10
“Cellular senescence is considered to be an important contributor to aging in many tissues and organs.((25)) We therefore explored whether the progeroid phenotype observed in CypB-deficient mice coincided with an increase in cellular correlates of senescence.”
BackgroundA Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker DevelopmentPreprint
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A. N., Shah, S., Ferrucci, L., Campisi, J., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3380253 · Cited by 18
BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer
Pun, R., Kumari, N., Monieb, R. H., Wagh, S., & North, B. J. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.005 · Cited by 10
Muscle-specific programmed cell death 5 deletion attenuates cardiac aging
Naz, A., Zhang, S., An, L. K., Song, Z., Zi, Z., Wu, J., Lai, S., Mazhar, H., Xu, M., Chen, Y., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.10.142 · Cited by 10
Jung, H., Choi, I. Y., Shin, D. W., Han, K., Yoo, J. E., Chun, S., & Yi, Y. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02291-4 · Cited by 14
Rhee, H., Han, M., Kim, S. S., Kim, I. Y., Lee, H. W., Bae, S. S., Ha, H. K., Jung, E. S., Lee, M. Y., Seong, E. Y., et al. (2018) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2018.37.3.222 · Cited by 11
Genetics of aging and longevity
Moskalev, A., Proshkina, E., Belyi, A. A., & Solovev, I. A. (2017) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059717040074 · Cited by 10
Immunosenescence in neurocritical care
Inoue, S., Saito, M., & Kotani, J. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0333-5 · Cited by 11
Caloric Restriction Improves Spatial Learning Deficits in Tau Mice
Cogut, V., McNeely, T. L., Bussian, T. J., Graves, S. I., & Baker, D. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231117 · Cited by 10
Self-citationChen, Y., Liang, L., Wu, C., Cao, Z., Xia, L., Meng, J., & Zuo, W. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0278 · Cited by 10
“Of note, loss of p16 in vivo pro-longs a healthy life span and delays aging-associated disorders (Baker et al. , 2011, 2016).”
Transglutaminase 2–mediated glutamine deamidation enhances p21 stability during senescence
Liao, Y.-W., Hsieh, H.-H., Yeh, J.-W., Wang, H.-C., Huang, S., Wang, P., & Lin, J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2419762122 · Cited by 11
Guo, E., Sun, L., Chen, W., Liu, C., Chen, K., Jiang, X., Qin, X., Su, J., Yang, F., & Tian, H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175775 · Cited by 11
In vitro and in vivo toxicity assessment of the senotherapeutic Peptide 14
Zonari, A. A. C., Brace, L. E., Alencar‐Silva, T., Porto, W. F., Foyt, D. A., Guiang, M., Cruz, E. A. O., Franco, O. L., Oliveira, C. R., Boroni, M., et al. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.07.018 · Cited by 9
Schöfer, S., Laffer, S., Kirchberger, S., Kothmayer, M., Löhnert, R., Ebner, E. E., Weipoltshammer, K., Distel, M., Pusch, O., & Schöfer, C. (2024) · European Journal of Histochemistry · doi:10.4081/ejh.2024.3977 · Cited by 12
DNA Homeostasis and Senescence: Lessons from the Naked Mole Rat
Boughey, H., Jurga, M., & El‐Khamisy, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116011 · Cited by 10
Length doesn't matter—telomere damage triggers cellular senescence in the ageing heart
Brand, T. (2019) · The EMBO Journal · doi:10.15252/embj.2019101571 · Cited by 9
Differential susceptibility and role for senescence in CART cells based on costimulatory domains
Can, İ., Siegler, E. L., Sirpilla, O. L., Manriquez-Roman, C., Yun, K., Stewart, C. M., Feigin, J. M., Rodriguez, M. L., Gutierrez-Ruiz, O. L., Ogbodo, E. J., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02371-1 · Cited by 11
“Senescing cells enter a terminal state in which the cell cycle is irreversibly arrested, gain resistance to apoptosis, and develop a proinflammatory senescence-associated secretory phenotype (SASP) that causes chronic inflammation [23, 24].”
Aging-Associated Mitochondrial Decline Accelerates Skin Aging and Obesity
Yamamura, S., Horiguchi, H., Kadomatsu, T., Miyata, K., Torigoe, D., Suzuki, T., Sato, M., Araki, K., Suzuki, A., Fukushima, S., et al. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.03.028 · Cited by 12
Stem Cell Models: A Guide to Understand and Mitigate Aging?
Brunauer, R., Alavez, S., & Kennedy, B. K. (2016) · Gerontology · doi:10.1159/000449501 · Cited by 12
Suk, K. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115737 · Cited by 13
Anti-aging strategies and ex vivo organ rejuvenation
Haoui, M., Reddy, P., & Belmonte, J. C. I. (2026) · Cell stem cell · doi:10.1016/j.stem.2025.12.011 · Cited by 13
Aging mechanisms and intervention targets
Liu, J. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12896 · Cited by 11
Convergent evolution of senescent fibroblasts in fibrosis and cancer with aging
Lee, J. Y., & Peng, T. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.002 · Cited by 14
Aging, Cellular Senescence, and Kidney Fibrosis
Susnik, N., Sen, P., Melk, A., & Schmitt, R. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0143-9 · Cited by 10
Liu, Y. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09162-1 · Cited by 8
“The pharmacological effects of CBD, including antidepressant, neu - roprotective, anti-inflammatory, and immunomodulatory [ 43 ].”
Sax, S. L., Centomo, M. L., Centofanti, F., Rizzacasa, B., Cox, S., Cox, C., Latini, A., D’Apice, M. R., Mannucci, L., Novelli, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111652 · Cited by 9
“Indeed, it has been demonstrated that the elimination of senescent cells with aging attenuates tumor formation in mice, raising the possibility that senolysis might be an effective strategy for preventing cancer [40].”
BackgroundInfluentialOtani, Y., Nozaki, Y., Mizunoe, Y., Kobayashi, M., & Higami, Y. (2023) · Pathology International · doi:10.1111/pin.13371 · Cited by 9
Khan, T., Hussain, A. I., Casilli, T. P., Frayser, L. A., Cho, M., Williams, G., McFall, D. J., & Forcelli, P. A. (2024) · Aging Cell · doi:10.1111/acel.14239 · Cited by 9
“While our study focused specifically on the brain, others have shown that senescent cell clearance reduced age-related degeneration in various tissues such as kidneys, cardiac tissue, and sarcopenia (Baker et al., 2011, 2016).”
BackgroundChen, Z., Mao, Q., Zhang, J., Wu, Y., Shan, X., Geng, Y., Fan, J., Cai, Z., & Xiang, R. (2025) · Aging Cell · doi:10.1111/acel.14470 · Cited by 15
“Conversely, the elimination of these cells can attenuate tissue dysfunction and improve health (Baker et al. 2016).”
TEAD4 antagonizes cellular senescence by remodeling chromatin accessibility at enhancer regions
Zhang, D., Zhu, Y., Ju, Y., Zhang, H., Zou, X., She, S., Zhu, D., & Guan, Y. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04980-9 · Cited by 8
Unveiling the link: aging and its impact on ocular diseases
Wang, K., Xie, Y., Lin, Y., Zhu, R., Gao, T., Han, Z., Yang, Z., Jiang, X., Chen, H., Wu, Z., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110551 · Cited by 13
Chemotherapy-induced cellular senescence suppresses progression of Notch-driven T-ALL
Zhang, Y., Gundelach, J. H., Lindquist, L. D., Baker, D. J., van Deursen, J., & Bram, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224172 · Cited by 9
Self-citationT cells engineered to target senescence
Wagner, V., & Gil, J. (2020) · Nature · doi:10.1038/d41586-020-01759-x · Cited by 9
p52 signaling promotes cellular senescence
Bernal, G. M., Wu, L., Voce, D. J., Weichselbaum, R. R., & Yamini, B. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00779-6 · Cited by 9
Rejuvenating the Aging Heart by Enhancing the Expression of the Cisd2 Prolongevity Gene
Yeh, C., Chou, Y.-J., Chu, T.-K., & Tsai, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111487 · Cited by 8
Therapeutic effects and perspective of stem cell extracellular vesicles in aging and cancer
Liu, Y., Cheng, Y., Wang, S., Su, Y., Liu, Y., Li, C., Jin, L., Wan, Q., Sang, X., & Wang, Z. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30212 · Cited by 9
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li, W., Xie, Y., Jia-Xin, M., Shu-Chao, G., & Li-Ping, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149480 · Cited by 11
Xiao, R., Hu, S., Du, X., Wang, Y., Fang, K., Zhu, Y., Lou, N., Yuan, C., & Yang, J. (2024) · Aging and Disease · doi:10.14336/ad.202.0565 · Cited by 12
“For example, the INK-ATTAC system has demonstrated inefficiencies in the removal of p16-expressing cells in various tissues, such as the liver, colon, and T lymphocytes [98].”
Regulatory Roles of Exosomes in Aging and Aging-Related Diseases
Xiao, N., Li, Q., Liang, G., Qian, Z., Lin, Y., Zhang, H., Fu, Y., Yang, X. M., Zhang, C., Yang, J., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10200-7 · Cited by 10
“In addition to activation by the p53/p21 pathway, Rb can also be activated by p16 (Palmero et al. 1997). p16, which functions as an inhibitor of the cyclin D/ Cyclin-dependent kinases 4 and 6 (CDK4/6) complex, is highly expressed in senescent cells (Baker et al. 2016).”
CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells
Mandl, M., Ritthammer, H., Ejaz, A., Wagner, S., Hatzmann, F. M., Baumgarten, S., Viertler, H. P., Zwierzina, M., Mattesich, M., Schiller, V., et al. (2020) · Adipocyte · doi:10.1080/21623945.2020.1834230 · Cited by 11
IGF2BP3/NCBP1 complex inhibits renal tubular senescence through regulation of CDK6 mRNA stability
Li, Y., Luo, C., Cai, Y., Wu, Y., Shu, T., Wei, J., Wang, H., & Niu, H. (2024) · Translational research · doi:10.1016/j.trsl.2024.06.004 · Cited by 9
Ishaq, A., Dufour, D., Cameron, K., von Zglinicki, T., & Saretzki, G. C. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.10.008 · Cited by 14
Cathepsin L induces cellular senescence by upregulating CUX1 and p16INK4a
Wu, Y., Jiang, D., Liu, Q., Yan, S., Liu, X., Wu, T., Sun, W., & Li, G. (2024) · Aging · doi:10.18632/aging.205955 · Cited by 11
“…(GWAS) functional studies on the aging-related CDKN2A/B locus [12], we recently demonstrated that CUX1 is an activator of p16 INK4a , regulating p16 INK4a -dependent cellular senescence via its binding to an atherosclerosis-associated functional SNP (fSNP) rs1537371 on the CDKN2A/B locus [13].”
BackgroundElectrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability
D’Ambrosio, M., White, M. E. H., Gavriil, E.-S., Bousset, L., Birch, J., Gruevska, A., Pasquini, E., Colucci, M., Fong, W., Mosole, S., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01921-z · Cited by 17
Engineering Antibodies Targeting p16 MHC-Peptide Complexes
Rettko, N. J., Campisi, J., & Wells, J. A. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00808 · Cited by 8
Research on the anti-ageing mechanism of Prunella vulgaris L.
Li, P., Lv, X., Wang, J., Zhang, C., Zhao, J., & Yang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-39609-1 · Cited by 10
“Baker et al. 33 claim that drug-induced elimination of P16 INK4A -positive senescent cells can stop or slow the onset of known age-related diseases and prolong healthy life.”
The regulatory networks and mechanisms of bone microenvironment in tumorigenesis and metastasis
Huang, G., Hou, T., Song, D., & Meng, T. (2025) · Journal of bone oncology · doi:10.1016/j.jbo.2025.100729 · Cited by 20
“[189]These therapeutics are distinguished by their structural diversity, favorable tissue penetration, and pharmacokinetic properties.”
Zhang, X., Huang, G., Zhang, Z., Wang, F., Liu, Q., Du, Y., Wang, X., & Gu, X. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112372 · Cited by 10
Niazi, S. K. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123904 · Cited by 8
Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
Han, X., Wang, S., Yong, Z., Zhang, X., Wang, X., & You, P. (2023) · Open Medicine · doi:10.1515/med-2023-0654 · Cited by 9
A defective splicing machinery promotes senescence through MDM4 alternative splicing
Deschênes, M., Durand, M., Olivier, M., Pellerin‐Viger, A., Rodier, F., & Chabot, B. (2024) · Aging Cell · doi:10.1111/acel.14301 · Cited by 11
“Given the role of senescent cell accumulation in physiological aging (Baker et al., 2008, 2011, 2016) and that splicing defects, including increased intron retention, are also established phenotypes of aging (Bhadra et al., 2020; Deschênes & Chabot, 2017), it is possible that defective splicing…”
Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics?
Yang, Z., Potenza, D. M., & Ming, X. (2025) · Biomolecules · doi:10.3390/biom15040545 · Cited by 13
“Indeed, the genetic model designed to deplete p16 ink4+ cells shows not only a reversal of the aging phenotype, including the heart aging phenotype, but also a reduction of atherosclerotic burden in mouse models [46,55].”
Zhan, D., Ma, D., Wei, S., Lal, B., Fu, Y., Eberhart, C. G., Laterra, J., Ying, M., Li, Y., Meeker, A. K., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0284 · Cited by 12
Polzer, O., Kinloch, E., & Fitzsimons, C. P. (2025) · Aging Brain · doi:10.1016/j.nbas.2025.100141 · Cited by 11
“Indeed, clearance of senescent cells within animal models extends lifespan and reduces occurrence of neurodegenerative diseases [9,11,16,147,153] .”
Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?
Pessoa, J., Pereira, S. N., & de Jesus, B. B. (2024) · Aging · doi:10.18632/aging.205975 · Cited by 10
Inflammaging: Expansion of Molecular Phenotype and Role in Age-Associated Female Infertility
Иванов, Д. О., Дробинцева, А. О., Rodichkina, V. R., Mironova, E. S., Zubareva, T. S., Krylova, Y. S., Morozkina, S. N., Marasco, M. G. P., Mazzoccoli, G., Nasyrov, R. A., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12091987 · Cited by 10
“Since the lack of regenerative potential is a hallmark of tissue aging, the population of aging cells is directly related to the whole-body aging and age-associated diseases [3].”
BackgroundSenescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation
Zhao, K., Yan, Y., Dong, B., Pan, S., & Zhang, X. (2025) · Advanced Materials · doi:10.1002/adma.202516597 · Cited by 10
Alterations of receptors and insulin-like growth factor binding proteins in senescent cells
Matuszewska, J., Krawiec, A., Radziemski, A., Uruski, P., Tykarski, A., Mikuła‐Pietrasik, J., & Książek, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151438 · Cited by 8
Loss of p16 does not protect against premature ovarian insufficiency caused by alkylating agents
Liu, F., Wan, Q., Liu, P., Miao, D., Dai, X., & Chen, L. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05476-x · Cited by 8
Sun, Y., Zhang, C., Ma, Q., Yu, X., Gao, X., Zhang, H., Shi, Y., Li, Y., & He, X. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03857-3 · Cited by 10
“Simultaneously, P16 INK4a -positive cells accumulating during adulthood negatively influence the lifespan and promote age-dependent changes in multiple organs, so their therapeutic removal may be an attractive approach to extending a healthy lifespan [39].”
BackgroundCorrea‐de‐Araujo, R., & Bhasin, S. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac181 · Cited by 7
JAK-STAT signaling mediates the senescence of cartilage-derived stem/progenitor cells
Ji, T., Chen, M., Sun, W., Zhang, X., Cai, H., Wang, Y., & Xu, H. (2022) · Journal of Molecular Histology · doi:10.1007/s10735-022-10086-6 · Cited by 9
Senescent Cells Drive Frailty through Systemic Signals
Lehmann, J., Baar, M. P., & de Keizer, P. L. J. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.003 · Cited by 10
Lattice percolation approach to 3D modeling of tissue aging
Gorshkov, V. N., Privman, V., & Libert, S. (2016) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2016.05.067 · Cited by 9
Saccà, S. C., Cutolo, C. A., & Rossi, T. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_14 · Cited by 8
Toward Systemic Lipofuscin Removal
Renteln, M. (2024) · Rejuvenation Research · doi:10.1089/rej.2024.0034 · Cited by 9
Machihara, K., Kageyama, S., Oki, S., Makino, H., Sasaki, M., Iwahashi, H., & Namba, T. (2022) · Aging · doi:10.18632/aging.204303 · Cited by 7
“Aging normal organs contain some senescent cells, and the removal of these senescent cells was found to restore organ function and extend life span in aged mice, indicating that cellular senescence induces whole-tissue functional decline [4, 5].”
Intracellular protons accelerate aging and switch on aging hallmarks in mice
Osanai, T., Tanaka, Μ., Izumiyama, K., Mikami, K., Kitajima, M., Tomisawa, T., Magota, K., Tomita, H., & Okumura, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27302 · Cited by 7
Yamamoto, H., Shimomura, N., & Hasegawa, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17060713 · Cited by 8
“Adipose tissue is thought to be a major source of senescent cells and aged mice possess depots in white adipose tissue that show positive SA-β -gal staining compared to young mice [40].”
BackgroundSilva, D. D. E., Borba, G. B., Beal, J. R., Botrus, G., Osawa, A., Araújo, S. E. A., Moura, F., Kaliks, R. A., & Usón, P. L. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044209 · Cited by 8
“three exons and encodes the p16INK4a and p14ARF proteins that inhibit the formation of the complex between CDK4/6 and cyclin D, protects p53 from being broken down, and induces the expression of p21, a CDK inhibitor [4,18,19].”
BackgroundExtracellular vesicles: the key to unlocking mechanisms of age-related vascular disease?
Whitehead, M., Antonazzi, M., & Shanahan, C. M. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.49 · Cited by 7
Czarnecka‐Herok, J., Zhu, K., Flaman, J., Goehrig, D., Vernier, M., Makulyte, G., Lamboux, A., Dragic, H., Rhinn, M., Médard, J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103204 · Cited by 9
Inflammaging and age-associated diseases
Manabe, I. (2017) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.54.105 · Cited by 7
Liao, C. M., Wulfmeyer, V. C., Swallow, M., Falk, C. S., Haller, H. G., Korstanje, R., Melk, A., & Schmitt, R. (2021) · Cells · doi:10.3390/cells10061437 · Cited by 8
Cell Culture Studies: A Promising Approach to the Metabolomic Study of Human Aging
Rocha, A., Magalhães, S., & Nunes, A. (2021) · Current Metabolomics and Systems Biology · doi:10.2174/2666338408666210322113713 · Cited by 8
Tian, T., Xue, Y., Song, Z., Jin-Smith, B., Barkin, J., Ottallah, M., Mannan, M., Zhirkova, A. M., Zhou, D., & Pi, L. (2025) · GeroScience · doi:10.1007/s11357-025-01952-8 · Cited by 7
“Senes-cent cells treated with AP eliminate themselves by mediating apoptosis [25].”
Measuring biological age in mice using differential mass spectrometry
Bell‐Temin, H., Yousefzadeh, M. J., Bondarenko, A. Y., Quarles, E. K., Jones-Laughner, J. M., Robbins, P. D., Ladiges, W., Niedernhofer, L. J., & Yates, N. A. (2019) · Aging · doi:10.18632/aging.101810 · Cited by 9
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.